European Companies Search Engine

EU funding (€12M): EXposome Powered tools for healthy living in urbAN SEttings Hor 1 Jan 2020 EU Research and Innovation programme "Horizon"

Text

EXposome Powered tools for healthy living in urbAN SEttings

By 2030 more than 80% of Europe’s population will live and interact with a complex urban environment, consisting of a mixture of social and environmental factors. These factors include: where we live and work, where and what we eat, our social network, and what chemical substances we are exposed to. Individually or collectively these factors, known as the Urban Exposome, have an often modifiable impact on our health and provide important targets to improve population health. By studying the impact of the Urban Exposome on the major contributors to Europe’s burden of disease: Cardio-Metabolic and Pulmonary Disease, EXPANSE will address one of the most pertinent questions for urban planners, policy makers, and European citizens: “How to maximize one’s health in a modern urban environment?”. EXPANSE will take the next step in Exposome research by: 1) bringing together the Exposome and health data of more than 55 million Europeans in administrative cohorts, in-depth Exposome, phenotype, and OMICs information for more than 2 million Europeans, and personalized Exposome assessment for 4,000 individuals living in five “Urban Labs”; 2) applying a novel approach to use ultra-high-resolution mass-spectrometry to agnostically screen for exogenous chemicals in 10,000 blood samples; 3) studying the evolution of the Exposome and health through the life-course via both (matured) birth and adult cohorts; and 4) evaluating the impact of changes in the Urban Exposome on the burden of Cardio-Metabolic and Pulmonary Disease. EXPANSE will translate its insights and innovations into research and dissemination tools that will be openly accessible via the EXPANSE toolbox. By applying innovative ethics-by-design throughout the project, the social and ethical acceptability of these tools will be safeguarded. Tool discoverability and accessibility will be stimulated through the EXPANSE hub in which citizens, public sector policy makers, and private sector companies collectively participate. EXPANSE is part of the European Human Exposome Network comprised of 9 projects selected from this same call


Funded Companies:

Company name Funding amount
Azienda Sanitaria Locale Roma 1 €277,862
Centre International de Recherche sur le Cancer €1,266,093
Emory University NON Profit Corp €214,813
Ethniko Kai Kapodistriako Panepistimio Athinon €427,195
Fundacion Privada Instituto de Salud Global Barcelona €566,223
Game Solutions LAB B.V. €133,995
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit UND Umwelt GmbH €615,341
Icahn School OF Medicine AT Mount Sinai €403,908
Imperial College of Science Technology and Medicine €993,136
Institut National de la Sante et de la Recherche Medicale €222,008
Instytut Medycyny Pracy Imienia prof. Dra Med. Jerzego Nofera w Lodzi €219,630
Karolinska Institutet €677,357
Masarykova Univerzita €398,834
Schweizerisches Tropen UND Public Health Institut €976,270
Sodaq Holding B.V. €142,809
Stichting Amsterdam UMC €338,283
Tartu Ulikool €271,305
Trustees OF Columbia University IN THE City OF NEW York €687,260
Universitair Medisch Centrum Utrecht €743,910
Universiteit Utrecht €2,342,675
Uniwersytet Jagiellonski €75,000

Source: https://cordis.europa.eu/project/id/874627

The filing refers to a past date, and does not necessarily reflect the current state.